WILLIAM A. HAGSTROM - 14 May 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Peter Maag as attorney-in-fact for William A. Hagstrom
Issuer symbol
CDNA
Transactions as of
14 May 2021
Net transactions value
-$668,884
Form type
4
Filing time
17 May 2021, 16:16:47 UTC
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $27,758 +4,745 +26% $5.85 23,320 14 May 2021 Direct
transaction CDNA Common Stock Options Exercise $26,380 +5,255 +23% $5.02 28,575 14 May 2021 Direct
transaction CDNA Common Stock Sale $573,868 -8,588 -30% $66.82 19,987 14 May 2021 Direct F1
transaction CDNA Common Stock Sale $95,016 -1,412 -7.1% $67.29 18,575 14 May 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Stock Option (right to buy) Options Exercise $27,758 -4,745 -90% $5.85 510 14 May 2021 Common Stock 4,745 $5.85 Direct F3
transaction CDNA Stock Option (right to buy) Options Exercise $26,380 -5,255 -100% $5.02 0 14 May 2021 Common Stock 5,255 $5.02 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.14 to $67.14, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.28 to $67.395, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 1/12th of the shares subject to the option vested on July 17, 2015 and 1/12th of the shares subject to the option vested monthly thereafter.
F4 1/12th of the shares subject to the option vested on July 16, 2016 and 1/12th of the shares subject to the option vested monthly thereafter.